Covalis Capital’s Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share AUS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-49,999
Closed -$262K 133
2021
Q3
$262K Hold
49,999
0.06% 85
2021
Q2
$263K Buy
+49,999
New +$72.4K 0.09% 84

Other funds holding AUS.WS

Covalis Capital's AUS.WS Position: Q4 2021 in Review

Covalis Capital sold out of Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share (AUS.WS) in Q4 2021, closing a stake of 49,999 shares — an estimated $262K sold.

Covalis Capital first reported a position in AUS.WS in Q2 2021 and held it in 2 quarters. The position peaked at $263K in Q2 2021. 67 funds tracked by Wall St. Rank hold AUS.WS as of Q4 2021.

  • Covalis Capital reported no remaining Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position as of Q4 2021 after selling out during the quarter.
  • Covalis Capital sold 49,999 Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share shares in Q4 2021, an estimated $262K.
  • Covalis Capital first reported a position in Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share in Q2 2021 and held it in 2 quarters.
  • Covalis Capital's Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share position peaked at $263K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share as of Q4 2021.

Based on Covalis Capital's 13F filing for Q4 2021, filed 14 Feb 2022.